PR Newswire - Global Registrational Phase III Study of Olveremba...
SUZHOU, China, and ROCKVILLE, Md., June 11, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (C...
Read More


ภาษาไทย
English